Aug 13, 2020
Palatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference
Jun 11, 2020
Real-World Data of Terlipressin in Hospitalized Patients in U.K. with Hepatorenal Syndrome Type 1 (HRS-1) Published in Alimentary Pharmacology and Therapeutics
Jun 04, 2020
Qualigen Therapeutics Receives U.S. Patent Notice of Allowance for its STARS(TM) Technology
May 28, 2020
Global Peptide Synthesis Market (2019 to 2025) - By Application, Type, Technology, Product, Type of Resin, Labelling, End-user, Region, Competition, Forecast & Opportunities - ResearchAndMarkets.com
May 21, 2020
Global Peptides and Macrocycle Drug Discovery Services and Platforms Market Outlook, 2020-2030 by Product, Drug Discovery Steps, Therapeutic Area, Company Size and Geography
May 12, 2020
Peptide Therapeutics: Contract API Manufacturing Market, 2020 - 2030
May 12, 2020
Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030
May 07, 2020
Stealth BioTherapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights
May 05, 2020
Portage makes an additional investment in Saugatuck therapeutics after achieving proof of concept
Apr 13, 2020
Stealth Biotherapeutics Announces $20 Million Financing to Advance Development of Elamipretide and Pipeline
Apr 01, 2020
Stealth BioTherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights
Apr 01, 2020
GenScript Launches Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development
Mar 03, 2020
FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
Feb 19, 2020
Palatin Technologies, Inc. Announces First Patient Enrolled in Dry Eye Disease Phase 2 Clinical Trial with PL9643
Feb 18, 2020
Aptamer Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025
Feb 11, 2020
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights
Feb 06, 2020
Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on February 11, 2020
Jan 16, 2020
FDA approves Ozempic® for cardiovascular risk reduction in adults with type 2 diabetes and known heart disease, updates Rybelsus® label
Jan 13, 2020
John Theurer Cancer Center Investigators Report Effectiveness of New Treatment for Refractory Multiple Myeloma
Dec 16, 2019
Customized Peptide Synthesis Market (2014-2024)